Breaking Barriers: Bio-Techne Takes the Stage at Top Investor Conferences

Bio-Techne Announces Investor Conference Presentations MINNEAPOLIS, Nov. 8, 2024 /PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH) today announced that it will present at the following investor conferences: Investor Conference Schedule UBS Global Healthcare Conference November 12, 2024 9:30 AM PST Stifel 2024 Healthcare Conference November 19, 2024 8:00 AM EST Stephens NASH 2024 Conference November 20,…

Read More

Breaking News: Bavarian Nordic’s Mpox Vaccine Approved by EMA for Adolescents!

COPENHAGEN, Denmark, September 19, 2024 – Bavarian Nordic A/S (OMX: BAVA) announced today that the European Commission has adopted the Committee for Medicinal Products for Human Use (CHMP) recommendation for the approval of a type II variation for IMVANEX® (MVA-BN) smallpox and mpox vaccine, extending the current marketing authorization to include adolescents 12 to 17…

Read More

“Mark Your Calendars: Iron Mountain Announces Fourth Quarter and Full Year 2024 Earnings Release and Conference Call!”

Welcome to Iron Mountain’s Financial Report Iron Mountain Incorporated to Share Fourth Quarter and Full Year 2024 Financial Results PORTSMOUTH, N.H.–(BUSINESS WIRE)– Iron Mountain Incorporated, a global leader in information management services, is set to release its fourth quarter and full year 2024 financial results on Thursday, February 13, 2025. The company will share this…

Read More

Levi Korsinsky: Filing a Securities Class Action for Revance Therapeutics (RVNC) Shareholders – A Heartfelt Pursuit of Justice

Important Investor Alert: Levi & Korsinsky, LLP Announces a Securities Class Action Lawsuit Against Revance Therapeutics, Inc. NEW YORK, Feb. 24, 2025 – Levi & Korsinsky, LLP announces that a class action securities lawsuit has been commenced in the United States District Court for the Northern District of California on behalf of investors who purchased…

Read More